Literature DB >> 10931150

Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry.

K Bendelja1, A Gagro, A Bace, R Lokar-Kolbas, V Krsulovic-Hresic, V Drazenovic, G Mlinaric-Galinovic, S Rabatic.   

Abstract

Acute RSV infection in infancy may produce some asthma-like symptoms and may be followed by a recurrent wheeze later in childhood. It has been proposed that RSV infection stimulates type-2 cytokine responses, resembling those found in atopy and asthma. Peripheral blood cells were obtained from RSV-infected infants (n = 30) and healthy controls (n = 10). After in vitro restimulation of the cells, intracellular IL-4 and interferon-gamma (IFN-gamma) were measured by flow cytometry. The cells from RSV-infected infants produced more IL-4 and less IFN-gamma than those from healthy controls. IL-4 production was more frequent in CD8 than in CD4 cells, and the bias toward IL-4 production was greatest in infants with mild infections, whereas IFN-gamma production increased with disease severity. Our conclusions are that RSV infection is associated with IL-4 production in peripheral T cells, and that peripheral blood in infants with severe disease may be depleted of cytokine-producing cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931150      PMCID: PMC1905700          DOI: 10.1046/j.1365-2249.2000.01297.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

Review 1.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

2.  Respiratory syncytial virus-specific antibody responses in immunoglobulin A and E isotypes to the F and G proteins and to intact virus after natural infection.

Authors:  R C Welliver; M Sun; S W Hildreth; R Arumugham; P L Ogra
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

3.  Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response.

Authors:  M Román; W J Calhoun; K L Hinton; L F Avendaño; V Simon; A M Escobar; A Gaggero; P V Díaz
Journal:  Am J Respir Crit Care Med       Date:  1997-07       Impact factor: 21.405

Review 4.  Role of respiratory infection in onset of asthma and chronic obstructive pulmonary disease.

Authors:  F D Martinez
Journal:  Clin Exp Allergy       Date:  1999-06       Impact factor: 5.018

5.  Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis.

Authors:  D Isaacs; C R Bangham; A J McMichael
Journal:  Lancet       Date:  1987-10-03       Impact factor: 79.321

6.  Inhibition of IgE production and normalization of airways responsiveness by sensitized CD8 T cells in a mouse model of allergen-induced sensitization.

Authors:  H Renz; G Lack; J Saloga; R Schwinzer; K Bradley; J Loader; A Kupfer; G L Larsen; E W Gelfand
Journal:  J Immunol       Date:  1994-01-01       Impact factor: 5.422

7.  Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells.

Authors:  M Connors; A B Kulkarni; C Y Firestone; K L Holmes; H C Morse; A V Sotnikov; B R Murphy
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

8.  Respiratory syncytial virus infections in SR Croatia, Yugoslavia.

Authors:  G Mlinarić-Galinović; I Ugrcić; J Bozikov
Journal:  Pediatr Pulmonol       Date:  1987 Sep-Oct

9.  Distinct types of lung disease caused by functional subsets of antiviral T cells.

Authors:  W H Alwan; W J Kozlowska; P J Openshaw
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

10.  Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes.

Authors:  T Defrance; J P Aubry; F Rousset; B Vanbervliet; J Y Bonnefoy; N Arai; Y Takebe; T Yokota; F Lee; K Arai
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

View more
  42 in total

1.  Elevated Levels of Type 2 Respiratory Innate Lymphoid Cells in Human Infants with Severe Respiratory Syncytial Virus Bronchiolitis.

Authors:  Luan D Vu; David Siefker; Tamekia L Jones; Dahui You; Ryleigh Taylor; John DeVincenzo; Stephania A Cormier
Journal:  Am J Respir Crit Care Med       Date:  2019-12-01       Impact factor: 21.405

2.  Respiratory Syncytial Virus Disease Severity Is Associated with Distinct CD8+ T-Cell Profiles.

Authors:  David T Siefker; Luan Vu; Dahui You; Andrew McBride; Ryleigh Taylor; Tamekia L Jones; John DeVincenzo; Stephania A Cormier
Journal:  Am J Respir Crit Care Med       Date:  2020-02-01       Impact factor: 21.405

Review 3.  A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus.

Authors:  Emma Rey-Jurado; Jorge Soto; Nicolás Gálvez; Alexis M Kalergis
Journal:  Hum Vaccin Immunother       Date:  2017-06-09       Impact factor: 3.452

Review 4.  Antenatal risk factors, cytokines and the development of atopic disease in early childhood.

Authors:  E K Chung; R L Miller; M T Wilson; S J McGeady; J F Culhane
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-01       Impact factor: 5.747

5.  Long-lived regulatory T cells generated during severe bronchiolitis in infancy influence later progression to asthma.

Authors:  Jason P Lynch; Rhiannon B Werder; Bodie F Curren; Md Al Amin Sikder; Ashik Ullah; Ismail Sebina; Ridwan B Rashid; Vivian Zhang; John W Upham; Geoff R Hill; Raymond J Steptoe; Simon Phipps
Journal:  Mucosal Immunol       Date:  2020-02-17       Impact factor: 7.313

6.  Respiratory syncytial virus differentially activates murine myeloid and plasmacytoid dendritic cells.

Authors:  Ivette Boogaard; Marijke van Oosten; Leonie S van Rijt; Femke Muskens; Tjeerd G Kimman; Bart N Lambrecht; Anne-Marie Buisman
Journal:  Immunology       Date:  2007-04-30       Impact factor: 7.397

7.  Decreased Toll-like receptor 8 expression and lower TNF-α synthesis in infants with acute RSV infection.

Authors:  Kreso Bendelja; Valerija Vojvoda; Neda Aberle; Jasna Cepin-Bogovic; Alenka Gagro; Gordana Mlinaric-Galinovic; Sabina Rabatic
Journal:  Respir Res       Date:  2010-10-14

8.  Decreased interferon-gamma response in respiratory syncytial virus compared to other respiratory viral infections in infants.

Authors:  J H Aberle; S W Aberle; W Rebhandl; E Pracher; M Kundi; T Popow-Kraupp
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

9.  Increased Toll-like receptor 4 expression in infants with respiratory syncytial virus bronchiolitis.

Authors:  A Gagro; M Tominac; V Krsulović-Hresić; A Baće; M Matić; V Drazenović; G Mlinarić-Galinović; E Kosor; K Gotovac; I Bolanca; S Batinica; S Rabatić
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

10.  Characterization of recombinant respiratory syncytial viruses with the region responsible for type 2 T-cell responses and pulmonary eosinophilia deleted from the attachment (G) protein.

Authors:  Matthew B Elliott; Karin S Pryharski; Qingzhong Yu; L A Boutilier; N Campeol; K Melville; Todd S Laughlin; C K Gupta; Robert A Lerch; Valerie B Randolph; Natisha A LaPierre; Kristen M Heers Dack; Gerald E Hancock
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.